JAMA Network Home
Sign In
Original Investigation

Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes

JAMA Internal Medicine 10.1001/jamainternmed.2026.3841

August 31, 2026 at 11:00 AM EDT

Read the full article

In this study, in the first season of availability, RSV vaccines were associated with improved RSV-associated outcomes among US Medicare beneficiaries residing in nursing homes.

Corresponding Author: Ryan E. Wiegand, PhD, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS H24-5, Atlanta, GA 30329 (rwiegand@cdc.gov).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.3841?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083126

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks